Gayatri BioOrganics
GAYATRIBIOORGANICSLTD NSE
Gayatri BioOrganics
ChemicalsNSE: GAYATRIBIOORGANICSLTD BSE: 524564 Commodity Chemicals
Key Fundamentals
MicrocapCommodity ChemicalsChemicalsMarket Cap
₹65.29 Cr
Volatility
Moderate
P/E Ratio
-65.5
EBITDA
₹-0.75 Cr
Return on Equity
2.02%
Debt to Equity
0
Book Value
₹-4.7
EPS
₹0
52W High
₹20.25
52W Low
₹6.25
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
3- Company has low interest coverage ratio.
- Promoter holding is low: 21.6%
- Promoter holding has decreased over last 3 years: -19.0%
Growth Rate
Revenue Growth
—
Net Income Growth
58.57% higher than
3Y
Cash Flow Change
20.29% higher than
3Y
ROE
4.12% higher than
3Y
ROCE
-15.76% higher than
3Y
EBITDA Margin (Avg.)
—
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.34 |
| Expenses | 0.18 | 0.07 | 0.1 | 0.18 | 0.15 | 0.11 | 0.08 | 0.1 | 0.18 | 0.12 | 0.13 | 0.32 | 2.33 |
| Operating Profit | -0.18 | -0.07 | -0.1 | -0.18 | -0.15 | -0.11 | -0.08 | -0.1 | -0.18 | -0.12 | -0.13 | -0.32 | 0.01 |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | 0.43% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0.02 | 0.04 | 0.04 | 0.05 | 0.06 | 0.07 | 0.08 | 0.07 | 0.08 | 0.09 | 0.09 | 0.1 | 0.11 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | -0.2 | -0.11 | -0.14 | -0.23 | -0.21 | -0.18 | -0.16 | -0.17 | -0.26 | -0.21 | -0.22 | -0.42 | -0.1 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.2 | -0.11 | -0.14 | -0.23 | -0.21 | -0.18 | -0.16 | -0.17 | -0.26 | -0.21 | -0.22 | -0.42 | -0.1 |
| EPS in Rs | -0.03 | -0.01 | -0.02 | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 | -0.05 | -0.01 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 256 | 137 | 79.32 | 173 | 155 | 0 | 0 | 0 | 1.67 | 0 | 0 | 0 | 2.34 |
| Expenses | 241 | 162 | 129 | 197 | 159 | 0.61 | 0.5 | 0.5 | 2.44 | 0.53 | 0.45 | 0.75 | 2.9 |
| Operating Profit | 15.31 | -24.81 | -49.21 | -23.86 | -3.61 | -0.61 | -0.5 | -0.5 | -0.77 | -0.53 | -0.45 | -0.75 | -0.56 |
| OPM % | 5.98% | -18.08% | -62.04% | -13.77% | -2.32% | — | — | — | -46.11% | — | — | — | -23.93% |
| Other Income | 1.27 | 0.96 | -16.53 | 11.87 | 2.1 | 85.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 9.39 | 12.74 | 11.57 | 0.19 | 4.71 | 0.01 | 0 | 0 | 0.03 | 0.15 | 0.28 | 0.36 | 0.39 |
| Depreciation | 2.37 | 2.13 | 5.34 | 6.96 | 9.29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 4.82 | -38.72 | -82.65 | -19.14 | -15.51 | 84.47 | -0.5 | -0.5 | -0.8 | -0.68 | -0.73 | -1.11 | -0.95 |
| Tax % | 18.26% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 26.25% | 0% | 0% | 0% | — |
| Net Profit | 3.93 | -38.73 | -82.65 | -19.14 | -15.51 | 84.47 | -0.5 | -0.5 | -1.01 | -0.68 | -0.73 | -1.11 | -0.95 |
| EPS in Rs | 0.77 | -6.27 | -10.49 | -2.43 | -1.97 | 10.72 | -0.06 | -0.06 | -0.13 | -0.09 | -0.09 | -0.14 | -0.12 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 50.92 | 61.78 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 |
| Reserves | -40.86 | -79.58 | -160 | -181 | -196 | -111 | -112 | -112 | -113 | -114 | -115 | -116 |
| Borrowings | 88.12 | 116 | 35.11 | 35.11 | 35.11 | 35.11 | 35.11 | 35.11 | 35.66 | 36.36 | 36.9 | 37.63 |
| Other Liabilities | 43.94 | 44 | 151 | 213 | 227 | 0.46 | 0.47 | 0.6 | 0.44 | 0.37 | 0.66 | 1.09 |
| Total Liabilities | 142 | 142 | 105 | 145 | 145 | 3.09 | 2.6 | 2.24 | 1.62 | 1.57 | 1.67 | 1.72 |
| Fixed Assets | 47.19 | 45.69 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 5.8 | 6.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 89.13 | 90 | 105 | 145 | 145 | 3.09 | 2.6 | 2.24 | 1.62 | 1.57 | 1.67 | 1.72 |
| Total Assets | 142 | 142 | 105 | 145 | 145 | 3.09 | 2.6 | 2.24 | 1.62 | 1.57 | 1.67 | 1.72 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1.07 | -26.48 | -13.76 | -2.62 | -0.59 | 84.59 | -0.52 | -0.4 | -0.56 | -0.69 | -0.55 | -0.74 |
| Investing | -7.1 | -1.42 | -0.75 | 2.62 | 0.82 | -83.86 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing | 4.48 | 28.02 | 15.53 | 0 | 0 | -0.01 | 0 | 0 | 0.56 | 0.7 | 0.54 | 0.73 |
| Net Cash Flow | -1.55 | 0.12 | 1.02 | 0 | 0.23 | 0.73 | -0.52 | -0.4 | -0.01 | 0.01 | -0.01 | 0 |
| Free Cash Flow | -5.04 | -28.17 | -16.06 | -2.62 | -0.59 | 84.59 | -0.52 | -0.4 | -0.56 | -0.69 | -0.55 | -0.74 |
| CFO/OP | 7 | 107 | 28 | 11 | 16 | -13,867 | 104 | 80 | 73 | 130 | 122 | 99 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 63.12 | 116 | 6.95 | 3.18 | 1.22 | — | — | — | 54.64 | — | — | — |
| Inventory Days | 62.87 | 98.3 | 0 | 0 | 0 | — | — | — | 0 | — | — | — |
| Days Payable | 58.8 | 79.17 | — | — | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | 67.19 | 135 | 6.95 | 3.18 | 1.22 | — | — | — | 54.64 | — | — | — |
| Working Capital Days | 5.32 | -103 | -366 | -212 | -271 | — | — | — | -7,049 | — | — | — |
| ROCE % | 14.68% | -27.28% | -209.87% | — | — | — | -21.01% | -26.53% | -54.61% | -44.54% | -40.72% | -92.02% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Gayatri BioOrganics insights
59 extracted metrics + investor summaries across FY11–FY26.
Documents
1
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
1 May - Gayatri BioOrganics says it is not a Large Corporate for FY2025-26; debt borrowing NIL. 1 May - Gayatri BioOrganics says it is not a Large Corporate for FY2025-26; debt borrowing NIL.
2
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
1 May - Gayatri BioOrganics says it is not a Large Corporate for FY2025-26; debt borrowing NIL. 1 May - Gayatri BioOrganics says it is not a Large Corporate for FY2025-26; debt borrowing NIL.
3
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30 Apr - Gayatri BioOrganics says it is not a Large Corporate; FY2026-27 initial disclosure not applicable. 30 Apr - Gayatri BioOrganics says it is not a Large Corporate; FY2026-27 initial disclosure not applicable.
4
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30 Apr - Gayatri BioOrganics says it is not a Large Corporate; FY2026-27 initial disclosure not applicable. 30 Apr - Gayatri BioOrganics says it is not a Large Corporate; FY2026-27 initial disclosure not applicable.
5
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
11 Apr - Submitted Regulation 74(5) compliance certificate for quarter ended 31.03.2026. 11 Apr - Submitted Regulation 74(5) compliance certificate for quarter ended 31.03.2026.
Frequently Asked Questions about Gayatri BioOrganics
What does Gayatri BioOrganics Ltd do?
Incorporated in 1993, Gayatri Bio-Organics Ltd manufactures Starch, its derivatives and related by-products, and development of customized application for value added starch derivatives.
Where is Gayatri BioOrganics Ltd (524564) listed?
Gayatri BioOrganics Ltd trades as GAYATRIBIOORGANICSLTD on the NSE and under code 524564 on the BSE.
Which sector does Gayatri BioOrganics Ltd belong to?
Gayatri BioOrganics Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the market capitalisation of Gayatri BioOrganics Ltd?
Gayatri BioOrganics Ltd has a market capitalisation of ₹65.29 Cr, which places it in the Small Cap band.
What is the PE ratio of Gayatri BioOrganics Ltd?
Gayatri BioOrganics Ltd trades at a PE ratio of -65.50, on earnings per share of ₹0, against a book value of ₹-4.7 per share.
What is the 52-week high and low of Gayatri BioOrganics Ltd?
Over the last 52 weeks Gayatri BioOrganics Ltd has traded between ₹6.25 and ₹20.25.
What is the Return on Equity (ROE) of Gayatri BioOrganics Ltd?
Gayatri BioOrganics Ltd reported a return on equity of 2.02%. Its debt-to-equity ratio is 0.00.
Company Information
Incorporated in 1993, Gayatri Bio-Organics Ltd manufactures Starch, its derivatives and related by-products, and development of customized application for value added starch derivatives.
Website gayatribioorganics.com
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524564.md for Gayatri BioOrganics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.